Literature DB >> 11420883

The in vitro biosynthesis and stability measurement with agyl-glycuronide isoformes of the main metabolite of ipriflavone.

K Jemnitz1, F Lévai, K Monostory, I Szatmári, L Vereczkey.   

Abstract

The formation and stability of 1-beta-glucuronide conjugate of the main metabolite of ipriflavone [7-(1-carboxy-ethoxy)-isoflavone] (CI)--were studied by using liver microsomes, hepatocytes, and isolated perfused liver of untreated and 3-methylcholanthrene (MC) treated dog and rat, and human liver microsomes. MC treatment enhanced the rate of conjugation twice as much as that of the control in the microsomes of both dogs and rats. Conjugation of CI by microsomes results in two metabolites, both sensitive to pH and temperature. Other two glucuronide forms appeared in experiments with hepatocytes and perfused liver. Mass spectrometry supported. The conclusion, assumption that both metabolites produced by microsomes are glucuronide conjugate isoforms of CI, and that they could be distinguished according to the intensity of peaks on FAB-MIKE spectra. The beta-glucuronidase enzyme hydrolysed only the 1-beta-glucuronide isomer, the other, migrated form remained unchanged. D-saccharic-acid-1,4-lactone, a specific inhibitor of beta-glucuronidase enzyme, decreased the rate of enzymatic cleavage. Standard curves of CI were prepared by HPLC, and 1-beta-CI-glucuronide was quantified according to the amount of CI formed by hydrolysis. The stability of conjugates greatly depends on pH and temperature, and the rate of degradation and isomerization is sensitive to the value of both. Lowering the pH from 7.4 to 5.0 and the temperature from 37 degrees C to 18 degrees C increased the stability of glucuronides. Increasing the pH to 12.0 results in very rapid acyl migration and hydrolysis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11420883     DOI: 10.1007/BF03192307

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  9 in total

Review 1.  Acyl glucuronides revisited: is the glucuronidation process a toxification as well as a detoxification mechanism?

Authors:  H Spahn-Langguth; L Z Benet
Journal:  Drug Metab Rev       Date:  1992       Impact factor: 4.518

Review 2.  Preparation of isolated rat liver cells.

Authors:  P O Seglen
Journal:  Methods Cell Biol       Date:  1976       Impact factor: 1.441

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 4.  UDP-glucuronosyltransferases.

Authors:  B Burchell; M W Coughtrie
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

5.  Effect of pH on acyl migration and hydrolysis of tolmetin glucuronide.

Authors:  M L Hyneck; A Munafo; L Z Benet
Journal:  Drug Metab Dispos       Date:  1988 Mar-Apr       Impact factor: 3.922

6.  Stability of acyl glucuronides in blood, plasma, and urine: studies with zomepirac.

Authors:  P C Smith; J Hasegawa; P N Langendijk; L Z Benet
Journal:  Drug Metab Dispos       Date:  1985 Jan-Feb       Impact factor: 3.922

7.  Preparation and properties of partially purified cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase from rabbit liver microsomes.

Authors:  T A van der Hoeven; M J Coon
Journal:  J Biol Chem       Date:  1974-10-10       Impact factor: 5.157

8.  The formation of beta-glucuronidase resistant glucuronides by the intramolecular rearrangement of glucuronic acid conjugates at mild alkaline pH.

Authors:  K A Sinclair; J Caldwell
Journal:  Biochem Pharmacol       Date:  1982-03-15       Impact factor: 5.858

Review 9.  Roles of UDP-glucuronosyltransferases in chemical carcinogenesis.

Authors:  K W Bock
Journal:  Crit Rev Biochem Mol Biol       Date:  1991       Impact factor: 8.250

  9 in total
  1 in total

1.  Epimeric methylsulfinyladenosine derivatives from the marine ascidian Herdmania momus.

Authors:  Jian Lin Li; Eun La Kim; Haibo Wang; Jongki Hong; Sook Shin; Chong-Kyo Lee; Jee H Jung
Journal:  Bioorg Med Chem Lett       Date:  2013-06-07       Impact factor: 2.823

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.